Haemonetics (HAE) Competitors $66.15 -0.77 (-1.15%) Closing price 03:59 PM EasternExtended Trading$66.13 -0.02 (-0.03%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HAE vs. ALGN, MMSI, ICUI, XRAY, QDEL, NEOG, STAA, CERS, OSUR, and UTMDShould you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Haemonetics vs. Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA QuidelOrtho Neogen STAAR Surgical Cerus OraSure Technologies Utah Medical Products Haemonetics (NYSE:HAE) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, community ranking, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Do institutionals and insiders believe in HAE or ALGN? 99.7% of Haemonetics shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.8% of Haemonetics shares are held by company insiders. Comparatively, 0.7% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to HAE or ALGN? In the previous week, Align Technology had 14 more articles in the media than Haemonetics. MarketBeat recorded 25 mentions for Align Technology and 11 mentions for Haemonetics. Align Technology's average media sentiment score of 1.48 beat Haemonetics' score of 1.11 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 21 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has higher valuation and earnings, HAE or ALGN? Align Technology has higher revenue and earnings than Haemonetics. Haemonetics is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHaemonetics$1.36B2.44$117.56M$3.3119.94Align Technology$3.98B3.12$421.36M$5.4931.25 Do analysts prefer HAE or ALGN? Haemonetics presently has a consensus price target of $97.89, indicating a potential upside of 48.34%. Align Technology has a consensus price target of $241.25, indicating a potential upside of 40.60%. Given Haemonetics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Haemonetics is more favorable than Align Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Haemonetics 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78Align Technology 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has more volatility and risk, HAE or ALGN? Haemonetics has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Does the MarketBeat Community prefer HAE or ALGN? Align Technology received 392 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 69.73% of users gave Align Technology an outperform vote while only 61.74% of users gave Haemonetics an outperform vote. CompanyUnderperformOutperformHaemoneticsOutperform Votes40561.74% Underperform Votes25138.26% Align TechnologyOutperform Votes79769.73% Underperform Votes34630.27% Is HAE or ALGN more profitable? Align Technology has a net margin of 10.54% compared to Haemonetics' net margin of 9.47%. Haemonetics' return on equity of 23.66% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Haemonetics9.47% 23.66% 8.82% Align Technology 10.54%13.84%8.51% SummaryAlign Technology beats Haemonetics on 12 of the 18 factors compared between the two stocks. Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HAE vs. The Competition Export to ExcelMetricHaemoneticsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$3.31B$4.43B$5.32B$19.29BDividend YieldN/A43.63%5.21%3.83%P/E Ratio25.9329.3626.7734.47Price / Sales2.4466.78390.2234.86Price / Cash10.4851.0838.2517.51Price / Book3.666.216.754.67Net Income$117.56M$67.60M$3.23B$1.02B7 Day Performance-4.86%-0.76%1.55%-2.17%1 Month Performance11.43%18.61%12.22%7.01%1 Year Performance-26.76%21.15%16.71%3.59% Haemonetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HAEHaemonetics4.3107 of 5 stars$66.15-1.1%$97.89+48.0%-28.2%$3.32B$1.36B26.042,820Positive NewsAnalyst ForecastALGNAlign Technology4.7747 of 5 stars$184.84-1.8%$241.25+30.5%-34.9%$13.40B$3.98B32.9523,200Positive NewsMMSIMerit Medical Systems4.1547 of 5 stars$98.10-0.7%$108.67+10.8%+17.2%$5.80B$1.39B48.096,850Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionICUIICU Medical4.7513 of 5 stars$138.00-2.4%$192.67+39.6%+27.3%$3.40B$2.42B-30.2014,500Insider TradeXRAYDENTSPLY SIRONA4.9508 of 5 stars$16.63-0.4%$20.36+22.5%-43.9%$3.31B$3.72B-8.0315,000QDELQuidelOrtho4.4943 of 5 stars$32.57-2.7%$44.33+36.1%-28.5%$2.20B$2.76B-1.087,000Positive NewsGap UpNEOGNeogen3.2325 of 5 stars$6.40-3.2%$9.00+40.6%-53.5%$1.39B$906.00M-2.922,110STAASTAAR Surgical4.077 of 5 stars$19.25+0.2%$24.63+27.9%-56.6%$953.38M$279.13M-46.95960Positive NewsAnalyst ForecastBuyback AnnouncementCERSCerus2.8916 of 5 stars$1.32-0.8%$3.50+165.2%-32.4%$252.33M$185.14M-12.00290OSUROraSure Technologies4.0307 of 5 stars$2.63+8.2%$3.00+14.1%-48.0%$196.72M$161.63M17.53840Analyst ForecastUTMDUtah Medical Products2.1655 of 5 stars$54.47-1.1%N/A-22.4%$178.77M$39.27M13.79180Positive NewsDividend Announcement Related Companies and Tools Related Companies Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives QuidelOrtho Alternatives Neogen Alternatives STAAR Surgical Alternatives Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HAE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
